Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staged approach to epilepsy management.

Martin J Brodie1, Patrick Kwan

  • 1Epilepsy Unit, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland.

Neurology
|April 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do the third-generation antiseizure medications provide the "magic bullet" for drug-resistant epilepsy? Focus on cenobamate.

Epilepsia·2025
Same author

Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy.

Epilepsia open·2025
Same author

The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.

Epilepsia open·2024
Same author

Editorial: Epidemiology of epilepsy and seizures.

Frontiers in epidemiology·2024
Same author

Work productivity, quality of life, and care needs: An unfolding epilepsy burden revealed in the Australian Epilepsy Project pilot study.

Epilepsia open·2024
Same author

Comparative effectiveness of digital mental healthcare models for adults with epilepsy: A study protocol of a randomized controlled trial.

Epilepsia open·2024
Same journal

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same journal

Association of Changes in Intrinsic Capacity With Cognitive Decline and Dementia: A Prospective Cohort Study.

Neurology·2026
Same journal

Role of the Upper Motor Neuron in the Generation of Fasciculations in Early Disease Stages of Amyotrophic Lateral Sclerosis.

Neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
See all related articles

Most newly diagnosed epilepsy patients achieve seizure control with initial antiepileptic drug (AED) therapy. Approximately 30-40% of patients face difficult-to-control epilepsy, necessitating tailored treatment plans.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • The natural history of treated epilepsy is crucial for effective pharmacologic and surgical management.
  • Understanding patient outcomes informs treatment strategies for newly diagnosed epilepsy.

Purpose of the Study:

  • To analyze the long-term outcomes of epilepsy patients initiating antiepileptic drug (AED) therapy.
  • To identify predictors of successful treatment and refractory epilepsy.

Main Methods:

  • Prospective follow-up of 525 unselected, untreated epilepsy patients for a median of 5 years.
  • Tracking seizure control rates with monotherapy and combination AEDs.
  • Analyzing factors influencing treatment response and prognosis.

Main Results:

Related Experiment Videos

  • 63% of patients achieved seizure freedom for at least one year.
  • 47% of drug-naïve patients responded to the first AED; 13% to the second.
  • Only 3% achieved control with two AEDs, and none with three; 11% with initial inadequate control later became seizure-free.
  • Patients were categorized into two groups: ~60% controlled by monotherapy, and 30-40% difficult to control.

    • Conclusions:

    • Newly diagnosed epilepsy patients can be divided into those responsive to monotherapy and those with refractory epilepsy.
    • Early, individualized management plans, considering seizure type and AED mechanisms, are essential.
    • Epilepsy surgery should be considered after failure of two treatment regimens; preventing refractory epilepsy is a key treatment goal.